Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxidized nanocellulose gel is a hydrogel formulation derived from cellulose that has been chemically modified through oxidation processes—most commonly using TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl) as a catalyst. This modification introduces carboxyl groups onto the cellulose backbone, enhancing its hydrophilicity and enabling the formation of stable three-dimensional networks in aqueous environments. The resulting gels exhibit high biocompatibility, tunable mechanical properties, and excellent water retention. Mechanism of action centers on providing a physical scaffold that mimics the extracellular matrix (ECM), supporting cell adhesion and proliferation while serving as a barrier or carrier for bioactive molecules. In biomedical applications—including wound healing and tissue engineering—the gel acts as an anti-adhesion barrier post-surgery or as a drug delivery vehicle with controlled release properties. Its surface chemistry allows for further functionalization to deliver drugs or cells in targeted therapies[5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxidized nanocellulose gel.